SEC 13F Intelligence

Everett Harris & Co /Ca/ / ABT

Everett Harris & Co /Ca/’s Abbott Laboratories Position

Does Everett Harris & Co /Ca/ own Abbott Laboratories (ABT)? Yes — 1.45M shares worth $149M (+1.92% of its 13F portfolio) as of Q1 2026, down from 1.46M shares the prior filed quarter.

Position Value
$149M
Q1 2026
Shares
1.45M
% of Portfolio
+1.92%
Quarters Held
30
currently held

Position History ABT

Reported value by quarter
Q4 ’18: $120MQ4 ’18Q1 ’19: $131MQ2 ’19: $138MQ3 ’19: $135MQ4 ’19: $140MQ4 ’19Q1 ’20: $133MQ2 ’20: $154MQ3 ’20: $182MQ4 ’20: $180MQ4 ’20Q1 ’21: $196MQ2 ’21: $189MQ3 ’21: $190MQ4 ’21: $226MQ4 ’21Q1 ’22: $188MQ2 ’22: $169MQ3 ’22: $151MQ4 ’22: $171MQ4 ’22Q1 ’23: $158MQ2 ’23: $170MQ3 ’23: $149MQ4 ’23: $170MQ4 ’23Q1 ’24: $174MQ2 ’24: $159MQ3 ’24: $174MQ4 ’24: $173MQ4 ’24Q1 ’25: $201MQ2 ’25: $203MQ3 ’25: $197MQ4 ’25: $183MQ4 ’25Q1 ’26: $149Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 20261.45M$149M+1.92%
Q4 20251.46M$183M+2.21%
Q3 20251.47M$197M+2.42%
Q2 20251.49M$203M+2.60%
Q1 20251.51M$201M+2.58%
Q4 20241.53M$173M+2.18%
Q3 20241.53M$174M+2.16%
Q2 20241.53M$159M+2.03%
Q1 20241.53M$174M+2.31%
Q4 20231.55M$170M+2.43%
Q3 20231.54M$149M+2.33%
Q2 20231.56M$170M+2.57%
Q1 20231.56M$158M+2.56%
Q4 20221.56M$171M+2.94%
Q3 20221.56M$151M+2.78%
Q2 20221.56M$169M+2.93%
Q1 20221.59M$188M+2.67%
Q4 20211.60M$226M+3.13%
Q3 20211.61M$190M+3.01%
Q2 20211.63M$189M+3.02%
Q1 20211.63M$196M+3.39%
Q4 20201.65M$180M+3.19%
Q3 20201.67M$182M+3.56%
Q2 20201.68M$154M+3.39%
Q1 20201.69M$133M+3.43%
Q4 20191.61M$140M+3.17%
Q3 20191.62M$135M+3.35%
Q2 20191.64M$138M+3.44%
Q1 20191.64M$131M+3.40%
Q4 20181.66M$120M+3.41%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Everett Harris & Co /Ca/’s full portfolio or all institutional holders of ABT.